$heff's $tation of $tocks & $olid DD

[$heff]

POZN ($9.74) will definitely be coiled like a rocket close to the April 30th PDUFA date. This is the short position from shortsqueeze.com and it is definitely telling on this play. SOMX bounced hard from $3.70 to over $10.00 on second day after approval. POZN keeps moving higher everyday on low volume. Selling is drying as April 30th approaches. The potential approval of Vimovo is much greater than what Silenor approval chances were because of the negative history of sleep drugs w/the FDA. Here is the "shorts" tale of the tape b/w POZN and SOMX. One drug waiting approval (Vimovo)& the other drug (Silenor) already approved. POZN has almost 50% in institutional holdings so that makes shares tougher to get IMO as institutions are much more likely to hold on and have to file and S-8 once they decide to sell.$heff